home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Edwards Lifesciences (NY:EW)

84.26 +2.62 (+3.21%)

Official Closing Price Updated: 7:00 PM EDT, Mar 9, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Edwards Lifesciences

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

21 22 Next >

Here's How Much $100 Invested In Edwards Lifesciences 20 Years Ago Would Be Worth Today ↗

November 01, 2023

Via Benzinga

Apple, AMD, Palantir Earnings On Deck This Week As Market Seeks Positive Catalysts In Fed Decision Week ↗

October 30, 2023

S&P 500 earnings is expected to grow in Q3, reversing a four-quarter slide, as the reporting season enters its third week.

Via Benzinga

Topics Economy Stocks

Weight-Loss Drugs Spooked Medical Device Stocks. Did Investors Overreact? ↗

October 27, 2023

Makers of devices to treat obesity-related conditions have struggled recently. Analysts say there's more to the story.

Via Investor's Business Daily

Why Edwards Lifesciences Stock Plummeted Today ↗

October 26, 2023

Investors trade on potential rather than trailing results, and they found the company's top-line guidance wanting.

Via The Motley Fool

Earnings Scheduled For October 25, 2023 ↗

October 25, 2023

Companies Reporting Before The Bell • Deutsche Bank (NYSE:DB) is estimated to report quarterly earnings at $0.52 per share on revenue of $7.65 billion.

Via Benzinga

US Stocks Poised For Mixed Start Ahead Of Meta Earnings: Analyst Sees Corporate Profits Providing 'Fundamental Ballast' To Market ↗

October 25, 2023

With numerous headwinds in play, analysts have stressed the importance of robust corporate profit growth to sustain valuations.

Via Benzinga

How Is The Market Feeling About Edwards Lifesciences? ↗

October 24, 2023

Via Benzinga

P/E Ratio Insights for Edwards Lifesciences ↗

October 12, 2023

Via Benzinga

10 Health Care Stocks With Whale Alerts In Today's Session ↗

October 24, 2023

Via Benzinga

Amazon, Alphabet, Meta, Intel Q3 Earnings This Week: Will Mega-Caps Shatter Forecasts And Revive Market? ↗

October 23, 2023

Factset data indicates that out of the 17% of the S&P 500 companies that have reported so far, 73% have reported positive EPS surprises.

Via Benzinga

Topics Stocks

How Is The Market Feeling About Edwards Lifesciences? ↗

October 06, 2023

Via Benzinga

Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 15 Years ↗

October 19, 2023

Via Benzinga

Edwards Lifesciences Faces European Scrutiny Over Patent Policies, Copycat Devices ↗

October 17, 2023

U.S. medical devices manufacturer Edwards Lifesciences Corp (NYSE: EW) is reportedly under the scrutiny of EU antitrust regulators for its patent practices and policies aimed at thwarting copycat...

Via Benzinga

Topics Intellectual Property

Expert Ratings for Edwards Lifesciences ↗

October 02, 2023

Via Benzinga

Here's How Much $100 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth Today ↗

September 28, 2023

Via Benzinga

Edwards Lifesciences Commits to Fair Competition Amid Regulatory Scrutiny, Analyst Upgrades Stock ↗

September 26, 2023

The European Commission conducted a surprise inspection at Edwards Lifesciences Corp's (NYSE: EW) facility within a European Union member state due to suspicions of potential market power abuse,...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 26, 2023 ↗

September 26, 2023

Via Benzinga

$1000 Invested In This Stock 15 Years Ago Would Be Worth $15,000 Today ↗

September 15, 2023

Via Benzinga

Looking Into Edwards Lifesciences's Recent Short Interest ↗

September 14, 2023

Via Benzinga

Cramer Says 'I Have No Idea What's Happening' To A Once-Favored Stock Down 35% YTD ↗

September 13, 2023

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Edwards Lifesciences Corporation (NYSE: EW) used to be "one of the greatest stocks of our time and, it’s now

Via Benzinga

Patients With Deadly Heart Disease Underdiagnosed, Including 66% of Women: AI-Powered Clinical Study Shows

September 08, 2023

Via Get News

Topics Artificial Intelligence

Expert Ratings for Edwards Lifesciences ↗

September 08, 2023

Via Benzinga

Why Analysts Say GE's Healthcare Spinoff Has $20 Upside

September 05, 2023

General Electric’s spinoff, GE HealthCare Technologies Inc., is delivering some impressive results and has growth opportunities well worth tuning in to.

Via MarketBeat

Analyst Ratings for Edwards Lifesciences ↗

August 17, 2023

Via Benzinga

(EW) - Analyzing Edwards Lifesciences's Short Interest ↗

August 15, 2023

Via Benzinga

$100 Invested In This Stock 15 Years Ago Would Be Worth $1,600 Today ↗

August 11, 2023

Via Benzinga

Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 10 Years ↗

August 31, 2023

Via Benzinga

Beyond Pills: 3 Non-Pharma Healthcare Stocks for Healthy Gains ↗

August 30, 2023

The demand for healthcare devices and tools are increasing which means their stocks will provide profits for investors.

Via InvestorPlace

Barron's Weekend Stock Picks: PayPal, Nikola And Icahn Enterprises' Challenges ↗

August 05, 2023

Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read.

Via Benzinga

Where Edwards Lifesciences Stands With Analysts ↗

August 01, 2023

Via Benzinga

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com